Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging.,Current Opinion in Cardiology

当前位置： X-MOL 学术 › Curr. Opin. Cardiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging.
Current Opinion in Cardiology ( IF 2.3 ) Pub Date : 2023-09-26 , DOI: 10.1097/hco.0000000000001080
Timothy Abrahams ₁ , Masashi Fujino , Adam J Nelson , Stephen J Nicholls

Affiliation

The aim of this study was to review the impact of combination lipid lowering with statins and proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors on coronary atherosclerosis using serial intravascular imaging.

中文翻译：